Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06246708Not ApplicableCompleted

Cultural Adaptation of a Self-help App for Grieving Syrian Refugees in Switzerland

Role: collaborator

NCT05651737Not ApplicableCompleted

App-based Psychosocial Intervention to Enhance Quality of Life in Arabic-speaking Refugees Residing in Switzerland

Role: collaborator

NCT04020224Not ApplicableWithdrawn

INTERCEPT Safety Evaluation on Whole Blood

Role: lead

NCT03601221Completed

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

Role: collaborator

NCT03486054Not ApplicableWithdrawn

INTERCEPT Safety Evaluation in Anemic Patients

Role: lead

All 5 trials loaded